Adalimumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Adalimumab (Humira®) in serum and plasma.
The solid phase (MTP) is coated with a highly specific monoclonal antibody against Adalimumab.
Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Legal Status: CE-Mark Pending
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Quality Control Certificates
Humira® is a trademark of Abbott Laboratories.
The Kit at a glance:
|Required Volume (µL)||10|
|Incubation Time (min)||105|
|Sample||Serum or Plasma|
|Package Size||96 Tests|
|Standard Range (ng/mL, 10x)||0-2000|
|Detection Limit (ng/mL)||4|
|Spike Recovery (%)||>95|
|Shelf Life (years)||2|